Given its critical role in protein synthesis and cell growth, translation is a promising target for cancer therapy. Inhibitors of translation can potentially reduce the production of oncogenic proteins and induce cancer cell death. Translation inhibitors, such as ribosome inhibitors and eIF4E inhibitors, are being explored in clinical trials for their efficacy in treating various cancers.
